Methylation Profile of Cancer Testis Antigens in Colorectal Cancer

被引：0

作者：

Abu, Nadiah ^{[1
]}

Bakarurraini, Nurul Ainaa Adilah Rus ^{[1
]}

Nasir, Siti Nurmi ^{[1
]}

Ishak, Muhiddin ^{[1
]}

Baharudin, Rashidah ^{[1
]}

Jamal, Rahman ^{[1
]}

Mutalib, Nurul Syakima Ab ^{[1
]}

机构：

[1] Univ Kebangsaan Malaysia, UKM Med Mol Biol Inst UMBI, Kuala Lumpur 56000, Malaysia

来源：

IRANIAN JOURNAL OF IMMUNOLOGY | 2023年 / 20卷 / 01期

关键词：

Tumor -associated Antigen; Cancer -testis Antigen; Epigenetics; Cancer vaccine; Immunotherapy; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; TUMOR; PROMOTER;

D O I：

10.22034/iji.2023.92600.2171

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background: Cancer testis antigens (CTAs) are a class of immune-stimulating antigens often overexpressed in many types of cancers. The usage of the CTAs as immunotherapy targets have been widely investigated in different cancers including melanoma, hematological malignancies, and colorectal cancer. Studies have indicated that the epigenetic regulation of the CTAs such as the methylation status may affect the expression of the CTAs. However, the report on the methylation status of the CTAs is conflicting. The general methylation profile of the CTAs, especially in colorectal cancer, is still elusive. Objective: To determine the methylation profile of the selected CTAs in our colorectal cancer patients. Methods: A total of 54 pairs of colorectal cancer samples were Results: We found that most of the CTAs were hypomethylated, and CCNA1 and TMEM108 genes were among the few CTAs that were hypermethylated. Conclusion: Overall, our brief report has managed to show the targets.

引用

页码：83 / 91

页数：9

共 50 条

[41] Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
Yujie Zhang
Yuxin Zhang
Li Zhang
[J]. Journal of Cancer Research and Clinical Oncology, 2019, 145 : 281 - 291
[42] Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy
Yang, Ping
Meng, Mei
Zhou, Quansheng
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
[43] MicroRNA Methylation in Colorectal Cancer
Kaur, Sippy
Lotsari-Salomaa, Johanna E.
Seppanen-Kaijansinkko, Riitta
Peltomaki, Paivi
[J]. NON-CODING RNAS IN COLORECTAL CANCER, 2016, 937 : 109 - 122
[44] DNA Methylation and Colorectal Cancer
Ashktorab, Hassan
Brim, Hassan
[J]. CURRENT COLORECTAL CANCER REPORTS, 2014, 10 (04) : 425 - 430
[45] Cancer/testis antigens: Structural and immunobiological properties
Kirkin, AF
Dzhandzhugazyan, KN
Zeuthen, J
[J]. CANCER INVESTIGATION, 2002, 20 (02) : 222 - 236
[46] Targeting cancer testis antigens in synovial sarcoma
Mitchell, Geoffrey
Pollack, Seth M.
Wagner, Michael J.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
[47] Expression of Cancer Testis Antigens (CTAs) in Plasmacytoma
Jungbluth, Achim
Frosina, Denise
Fayad, Miriam
Dogan, Ahmet
Chiu, April
[J]. MODERN PATHOLOGY, 2015, 28 : 353A - 353A
[48] Cancer-testis antigens in haematological malignancies
Meklat, Farouk
Li, Zhanfei
Wang, Zhiqing
Zhang, Yana
Zhang, Jian
Jewell, Andrew
Lim, Seah H.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (06) : 769 - 776
[49] Expression of Cancer Testis Antigens (CTAs) in Plasmacytoma
Jungbluth, Achim
Frosina, Denise
Fayud, Miriam
Dogan, Ahmed
Chiu, April
[J]. LABORATORY INVESTIGATION, 2015, 95 : 353A - 353A
[50] Targeting SSX cancer–testis antigens for immunotherapy
Annette Fenner
[J]. Nature Reviews Urology, 2011, 8 (12) : 647 - 647

← 1 2 3 4 5 →